HOSPITAL AUTHORITY DRUG FORMULARY (v17.1 - w.e.f. 10 Jul 2021) drugs newly added to each category are highlighted in "yellow"
(1) The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand. (2) Some drugs may appear in more than one category due to different formulations and/or indications. (3) The "Special" drugs will be prescribed as clinically indicated based on the specified indications. (4) Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed in the HA Drug Formulary.
Self-financed item Self-financed item BNF General Drugs Special Drugs With Safety Net Without Safety Net 6 ENDOCRINE SYSTEM 內分泌系統藥物 6.1 DRUGS USED IN DIABETES DEXTROSE ACARBOSE DULAGLUTIDE DIAZOXIDE ALOGLIPTIN EXENATIDE GLICLAZIDE ALOGLIPTIN + PIOGLITAZONE LIRAGLUTIDE (VICTOZA) GLIMEPIRIDE BIPHASIC INSULIN ASPART LIXISENATIDE GLIPIZIDE BIPHASIC INSULIN LISPRO SEMAGLUTIDE GLUCAGON DAPAGLIFLOZIN INSULIN HUMAN (HUMULIN/ MIXTARD) DAPAGLIFLOZIN + METFORMIN INSULIN ISOPHANE HUMAN DULAGLUTIDE INSULIN NEUTRAL HUMAN EMPAGLIFLOZIN METFORMIN EXENATIDE INSULIN ASPART HUMAN INSULIN DEGLUDEC INSULIN DEGLUDEC + ASPART INSULIN DEGLUDEC + LIRAGLUTIDE INSULIN DETEMIR INSULIN GLARGINE INSULIN GLARGINE + LIXISENATIDE INSULIN GLULISINE INSULIN LISPRO HUMAN LINAGLIPTIN LINAGLIPTIN + METFORMIN LIRAGLUTIDE (VICTOZA) LIRAGLUTIDE (SAXENDA) LIXISENATIDE METFORMIN PIOGLITAZONE PIOGLITAZONE + METFORMIN SAXAGLIPTIN SAXAGLIPTIN + METFORMIN SEMAGLUTIDE SITAGLIPTIN SITAGLIPTIN + METFORMIN VILDAGLIPTIN VILDAGLIPTIN + METFORMIN 6.2 THYROID AND ANTITHYROID DRUGS CARBIMAZOLE IODINE + POTASSIUM IODIDE LIOTHYRONINE METHIMAZOLE PROPYL THIOURACIL THYROXINE 6.3 CORTICOSTEROIDS BETAMETHASONE DEXAMETHASONE FLUDROCORTISONE Self-financed item Self-financed item BNF General Drugs Special Drugs With Safety Net Without Safety Net HYDROCORTISONE METHYLPREDNISOLONE PREDNISOLONE TRIAMCINOLONE ACETONIDE 6.4 SEX HORMONES PROGESTERONE ETHINYLOESTRADIOL ACTIVELLE (OR EQUIV) (VAGINAL) MEDROXYPROGESTERONE ACETATE DIENOGEST TIBOLONE NORETHISTERONE DYDROGESTERONE OESTROGENS CONJUGATED FEMOSTON (OR EQUIV) FINASTERIDE (PROSCAR) SUSTANON (OR EQUIV) (OR EQUIV) TESTOSTERONE (TOPICAL) KLIOGEST (OR EQUIV) TESTOSTERONE ENANTHATE NOVOFEM (OR EQUIV) TESTOSTERONE UNDECANOATE OESTRADIOL OESTROGEL (OR EQUIV) OESTROGENS CONJUGATED PROGESTERONE PROGESTERONE (VAGINAL) RALOXIFENE TRISEQUENS (OR EQUIV) HYPOTHALAMIC AND PITUITARY HORMONES AND 6.5 ANTI-OESTROGENS CLOMIPHENE CHORIOGONADOTROPIN ALFA SOMATROPIN FOLLITROPIN ALFA CORTICORELIN (HUMAN) DESMOPRESSIN (DDAVP) TOLVAPTAN (JINARC) FOLLITROPIN BETA HUMAN CHORIONIC DESMOPRESSIN (DDAVP) GONADOTROPHIN PROTIRELIN MENOTROPHIN TERLIPRESSIN SOMATROPIN TETRACOSACTIDE THYROTROPIN ALFA VASOPRESSIN TOLVAPTAN (SAMSCA) 6.6 DRUGS AFFECTING BONE METABOLISM ALENDRONATE + ZOLEDRONIC ACID (ZOMETA) ALENDRONATE CHOLECALCIFEROL CLODRONATE DENOSUMAB (PROLIA) DENOSUMAB (PROLIA) DENOSUMAB (XGEVA) IBANDRONIC ACID DENOSUMAB (XGEVA) (BONDRONAT) IBANDRONIC ACID (BONVIVA) PAMIDRONATE RISEDRONATE ROMOSOZUMAB SALCATONIN SALCATONIN (NASAL) TERIPARATIDE ZOLEDRONIC ACID (ACLASTA) 6.7 OTHER ENDOCRINE DRUGS BROMOCRIPTINE CABERGOLINE DANAZOL CETRORELIX METYRAPONE QUINAGOLIDE 6.A MISCELLANEOUS (ENDOCRINE SYSTEM) UREA (POWDER)